CytarabineAcute DiseaseOxidesTreatment OutcomeStrokeIdarubicinDaunorubicinLeukemia, Myeloid, AcuteRemission InductionConsolidation ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsMitoxantroneAntimetabolites, AntineoplasticArabinonucleosidesLeukemia, MyeloidEtoposideThioguanineDrug Administration ScheduleMethotrexateInduction ChemotherapyVincristineMeningeal CarcinomatosisPrecursor Cell Lymphoblastic Leukemia-LymphomaInjections, SpinalLeukemic InfiltrationCytidine MonophosphateCarmustineDisease-Free SurvivalAsparaginaseDrug AgonismCyclophosphamideLymphoma, Non-Hodgkin6-MercaptopurineDeoxycytidine KinaseLeukemia, Myelomonocytic, AcuteArabinonucleotidesRecurrenceSurvival AnalysisLeukemia, Myeloid, Accelerated PhaseSurvival RateCentral Nervous System NeoplasmsAmsacrineTransplantation, AutologousVidarabineSalvage TherapyArabinofuranosylcytosine TriphosphateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDoxorubicinAnemia, Refractory, with Excess of BlastsTeniposideMyelodysplastic SyndromesCombined Modality TherapyDexamethasoneAntineoplastic AgentsLeukemiaMeningitisMelphalanDrug Resistance, NeoplasmPodophyllotoxinCladribineLeukemia, Myeloid, Chronic-PhasePrednisoneBlast CrisisAdenine NucleotidesInfusions, IntravenousDioxolanesPrognosisPolyradiculopathyHarringtoninesAclarubicinHematopoietic Stem Cell TransplantationActuarial AnalysisDose-Response Relationship, DrugCytogenetic AnalysisGranulocyte Colony-Stimulating FactorBurkitt LymphomaMeningesBenzamidesEquilibrative Nucleoside Transporter 1PyrimidinesPiperazinesBone Marrow TransplantationCore Binding FactorsAminoglycosidesLeukemia, Promyelocytic, AcuteLeukoencephalopathy, Progressive MultifocalLymphoma, Mantle-CellDrug SynergismAntibodies, Monoclonal, Murine-DerivedAzacitidinePapilledemaFollow-Up StudiesInterferon-alphaLymphomaNucleoside Transport ProteinsBenzenesulfonatesAnthracyclinesDrug EvaluationCytogeneticsPrednisolone